Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip T Edeen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Biotechnology|January 10, 2008
A quantitative analysis of kinase inhibitor selectivityMazen W Karaman, Sanna Herrgard, Daniel K Treiber, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2005
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinasesTodd A Carter, Lisa M Wodicka, Neil P Shah, et al.
Nature Biotechnology|February 16, 2005
A small molecule-kinase interaction map for clinical kinase inhibitorsMiles A Fabian, William H Biggs, Daniel K Treiber, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Biotechnology|January 10, 2008
A quantitative analysis of kinase inhibitor selectivityMazen W Karaman, Sanna Herrgard, Daniel K Treiber, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2005
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinasesTodd A Carter, Lisa M Wodicka, Neil P Shah, et al.
Nature Biotechnology|February 16, 2005
A small molecule-kinase interaction map for clinical kinase inhibitorsMiles A Fabian, William H Biggs, Daniel K Treiber, et al.
Pageof 2